A differential diagnosis is a way to distinguish between possible causes. It helps in the identification of the potential infections or illnesses that may be responsible for your symptoms. People should look at their medical history and present symptoms as well as the results of their physical exam to help them distinguish between possible causes. For cellulitis, the patient should exhibit symptoms such as a leg that is red, swollen, and sensitive to the touch (Sullivan & de Barra, 2018). The medical professional can also identify the causes to determine the best treatment.
Cellulitis is a common bacterial skin illness that may be unpleasant and causes redness and swelling of the afflicted area (Raff & Kroshinsky, 2016). Semisynthetic penicillins can be used for cellulitis treatment (Mukherji, et al. (2014). It provides increased protection and efficacy for a number of bacterias, including anaerobic and staphylococcal species as well as gram-negative.
Clinical results and other factors may determine the efficacy of semisynthetic Penicillins. A medication’s ability control infections-related signs or symptoms will be the clinical objective. The semisynthetic penicillins can be used to relieve the reddening, swelling, or discomfort in the affected region. (Saleh’ 2020). You may experience nausea, diarrhea, blackening of the tongue, vomiting and stomach pain, as well as irritation.
A side effect of antibiotic therapy might cause diarrhea (Saleh 2020). A semisynthetic penicillin might lead to moderate diarrhea. Clostridium Difficile infections can be defined as diarrhea that lasts longer than three days. It is usually accompanied with diarrhea, fever, blood in stool, abdominal discomfort, and a high heart beat. There may also be 10-15 episodes each day. The therapy for Clostridium Difficile infection will include restricting the use of prescription antibiotics (semi-synthetic penicillins), urging the patient to wash their hands, and doing a thorough cleaning of the patient’s environment (Bagdasarian, Rao, & Malani, 2019). Clostridium difficile therapy includes probiotics like fidaxomicin.